 | |
| Clinical data | |
|---|---|
| Other names | N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine; MDM1EA; α,N-Dimethyl-3,4-methylenedioxybenzylamine; α,N-DMMDBA; α,N-Dimethylpiperonylamine; α,N-Dimethyl-1,3-benzodioxole-5-methanamine |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H13NO2 |
| Molar mass | 179.219 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine (MDM1EA), also known asα,N-dimethyl-3,4-methylenedioxybenzylamine (α,N-DMMDBA) or asα,N-dimethylpiperonylamine, is anentactogen-likedrug of thebenzylamine family related toMDMA.[1][2][3] It is theanalogue of MDMA in which theside chain has been shortened by onecarbonatom.[1][2][3]
The drug has been found to be a weakserotonin reuptake inhibitor and partially substituted for MDMA in rodentdrug discrimination tests at the highest assessed doses.[1][2][4][3] The effects of α,N-DMMDBA in humans are unknown.[1]
It is not acontrolled substance in theUnited States as of 2011.[1]
Homo-MDMA (HMDMA), an analogue of MDMA in which the side chain was extended by one carbon atom, has also beensynthesized and studied.[2][3] It partially substituted for MDMA similarly to MDM1EA.[2][3]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |
